Published in Hepatitis Weekly, July 23rd, 2007
"In this study, we constructed a recombinant DNA-based HCV system that contained EF-1alpha promoter-driven HCV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.